|
pubmed:abstractText |
The in vitro activities of Y-688, a new 7-substituted fluoroquinolone derivative, against 317 nonduplicate anaerobic isolates were determined. Eighty-five percent of the Bacteroides fragilis group (n = 89) were inhibited by < or = 2 mg of Y-688 per liter, while 78, 100, 89, and 98% of gram-negative bacilli (n = 135), gram-positive cocci (n = 59), and non-spore-forming (n = 58) and spore-forming (n = 51) gram-positive bacilli, respectively, were inhibited by < or = 1 mg of Y-688 per liter.
|
|
pubmed:affiliation |
Bristol Centre for Antimicrobial Research and Evaluation, University of Bristol, Department of Medical Microbiology, Southmead Hospital, Westbury-on-Trym, United Kingdom. STAFF@BCARE.ORG.UK
|
